Compare CLLS & USCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLLS | USCB |
|---|---|---|
| Founded | 1999 | 2002 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 384.3M | 353.1M |
| IPO Year | 2014 | 2021 |
| Metric | CLLS | USCB |
|---|---|---|
| Price | $3.24 | $18.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $8.50 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 48.3K | 32.6K |
| Earning Date | 03-19-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.70% |
| EPS Growth | N/A | ★ 7.26 |
| EPS | N/A | ★ 1.33 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $26.46 |
| Revenue Next Year | N/A | $9.67 |
| P/E Ratio | ★ N/A | $13.93 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.10 | $15.39 |
| 52 Week High | $5.48 | $20.79 |
| Indicator | CLLS | USCB |
|---|---|---|
| Relative Strength Index (RSI) | 42.08 | 46.33 |
| Support Level | $3.32 | $17.80 |
| Resistance Level | $3.83 | $18.58 |
| Average True Range (ATR) | 0.21 | 0.53 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 22.37 | 66.95 |
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.